Key Dates
- Board Meeting Date: Thursday, November 5, 2026
- Trading Window Closure Period: From October 1, 2026 until 48 hours after the declaration of unaudited financial results on November 5, 2026
Purpose of Board Meeting
The Board of Directors of Fermenta Biotech Limited will meet to consider and approve the unaudited financial results (both standalone and consolidated) for the quarter and half year ended September 30, 2026.
Trading Window Closure Details
The company has implemented a trading window closure in accordance with:
- SEBI (Prohibition of Insider Trading) Regulations, 2015
- The Company's Code of Conduct to Regulate, Monitor and Report Trading by Insiders
- BSE Circular LIST/COMP/01/2019-20 dated April 2, 2019
- The company's intimation to BSE Limited regarding closure of trading window dated September 29, 2026
During this closure period, the following persons are prohibited from trading in the company's securities:
- All Directors
- Promoters
- Insiders
- Designated Persons and their immediate relatives
- Auditors
- Other Connected Persons
The prohibition applies to direct or indirect trading, dealing, or entering into any transaction involving sale or purchase of the company's equity shares, whether in their own name or in the name of immediate relatives.